Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Noguera, Rosa" or (type any "bookEditor issueEditor" and editor="Noguera, Rosa")

Add to list
- Journal Article
- A1
- open access
A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma

Laura D. Gamble, Stefania Purgato, Michelle J. Henderson, Simone Di Giacomo, Amanda J. Russell, Paolo Pigini, Jayne Murray, Emanuele Valli, Giorgio Milazzo, Federico M. Giorgi, et al.

(2021) CANCERS. 13(8).
Add to list
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(30). p.3377-3390
Add to list
- Journal Article
- A1
- open access
11q deletion or ALK activity curbs DLG2 expression to maintain an undifferentiated state in neuroblastoma

Joachim Tetteh Siaw, Niloufar Javanmardi, Jimmy Van den Eynden (UGent) , Dan Emil Lind, Susanne Fransson, Angela Martinez-Monleon, Anna Djos, Rose-Marie Sjöberg, Malin Östensson, Helena Carén, et al.

(2020) CELL REPORTS. 32(12).
Add to list
The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition

Laura Gamble, Stefania Purgato, Simone Di Giacomo, Amanda Russell, Paolo Pigini, Emanuele Valli, Lesley Ashton, Tom Van Maerken (UGent) , Jo Vandesompele (UGent) , Rogier Versteeg, et al.

(2018) Advances in Neuroblastoma Research, Congress abstracts.
Add to list
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Fjoralba Zeka (UGent) , Anneleen Decock (UGent) , Alan Van Goethem (UGent) , Katrien Vanderheyden, Fleur Demuynck, Tim Lammens (UGent) , Hetty Helsmoortel (UGent) , Joëlle Vermeulen, Rosa Noguera, Ana P. Berbegall, et al.

(2018) JCI INSIGHT. 3(23).
Add to list
- Journal Article
- A1
- open access
Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt, Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2018) JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 110(10).
Add to list
- Conference Paper
- C3
- open access
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Bram De Wilde (UGent) , Bénédicte Brichard, Rosa Noguera, Franki Speleman (UGent) and Jo Vandesompele (UGent)

(2017) OncoPoint, 5th Research seminar, Abstracts.
Add to list
- Conference Paper
- C3
Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets

Pauline Depuydt, Valentina Boeva, Toby Hocking, Robrecht Cannoodt (UGent) , Inge Ambros, Peter Ambros, Shahab Asgharzadeh, Edward Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2017) Big Data in Biology and Health, Abstracts.
Add to list
- Conference Paper
- C3
Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Pauline Depuydt, Valentina Boeva, Toby D Hocking, Robrecht Cannoodt (UGent) , Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari, et al.

(2017) Cancer Genomics, 3rd EACR conference, Abstracts.
Add to list
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Bram De Wilde (UGent) , Bénédicte Brichard, Rosa Noguera, Franki Speleman (UGent) and Jo Vandesompele (UGent)

(2016) EPIGENETICS. 11(10). p.761-771

Academic Bibliography

A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

11q deletion or ALK activity curbs DLG2 expression to maintain an undifferentiated state in neuroblastoma

The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Genomic amplifications and distal 6q loss : novel markers for poor survival in high-risk neuroblastoma patients

Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait

Identification of novel, rare markers for poor survival in high-risk neuroblastoma patients by merging and reanalysing existing datasets

Genomic amplifications and distal 6q loss are novel markers for poor survival in high-risk neuroblastoma patients

Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait

Contents

Support

Contact